Aristides Capital LLC Makes New $245,000 Investment in TriMas Co. (NASDAQ:TRS)

Aristides Capital LLC purchased a new stake in TriMas Co. (NASDAQ:TRSFree Report) during the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 9,587 shares of the industrial products company’s stock, valued at approximately $245,000.

Other institutional investors and hedge funds also recently modified their holdings of the company. Innealta Capital LLC acquired a new stake in TriMas in the 2nd quarter valued at $26,000. Quantbot Technologies LP raised its holdings in TriMas by 5.7% during the first quarter. Quantbot Technologies LP now owns 8,933 shares of the industrial products company’s stock worth $239,000 after acquiring an additional 478 shares in the last quarter. Algert Global LLC boosted its position in TriMas by 4.2% during the second quarter. Algert Global LLC now owns 15,779 shares of the industrial products company’s stock valued at $403,000 after purchasing an additional 639 shares during the last quarter. BNP Paribas Financial Markets grew its stake in TriMas by 79.8% in the first quarter. BNP Paribas Financial Markets now owns 20,225 shares of the industrial products company’s stock valued at $541,000 after purchasing an additional 8,978 shares in the last quarter. Finally, Diversified Trust Co increased its position in shares of TriMas by 32.7% during the 1st quarter. Diversified Trust Co now owns 21,647 shares of the industrial products company’s stock worth $579,000 after purchasing an additional 5,333 shares during the last quarter. 99.42% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Separately, BWS Financial reissued a “buy” rating and issued a $40.00 price objective on shares of TriMas in a research report on Wednesday, July 31st.

View Our Latest Research Report on TRS

TriMas Trading Down 0.1 %

Shares of TriMas stock opened at $25.53 on Tuesday. The company has a debt-to-equity ratio of 0.63, a quick ratio of 1.48 and a current ratio of 2.82. The firm has a 50-day moving average of $24.89 and a 200-day moving average of $25.70. TriMas Co. has a 52-week low of $22.45 and a 52-week high of $27.89. The stock has a market cap of $1.04 billion, a PE ratio of 26.32 and a beta of 0.68.

TriMas (NASDAQ:TRSGet Free Report) last announced its earnings results on Tuesday, July 30th. The industrial products company reported $0.43 EPS for the quarter, missing the consensus estimate of $0.53 by ($0.10). TriMas had a return on equity of 9.61% and a net margin of 4.44%. The business had revenue of $240.50 million for the quarter, compared to the consensus estimate of $238.63 million. During the same period in the prior year, the business posted $0.50 earnings per share. The firm’s revenue for the quarter was up 3.1% compared to the same quarter last year. As a group, sell-side analysts forecast that TriMas Co. will post 1.76 EPS for the current year.

TriMas Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, August 13th. Shareholders of record on Tuesday, August 6th were issued a $0.04 dividend. This represents a $0.16 annualized dividend and a yield of 0.63%. The ex-dividend date of this dividend was Tuesday, August 6th. TriMas’s dividend payout ratio is currently 16.49%.

About TriMas

(Free Report)

TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.

See Also

Want to see what other hedge funds are holding TRS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for TriMas Co. (NASDAQ:TRSFree Report).

Institutional Ownership by Quarter for TriMas (NASDAQ:TRS)

Receive News & Ratings for TriMas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TriMas and related companies with MarketBeat.com's FREE daily email newsletter.